Magli G, Scimone C, Flaminio G, D'Alessandro G, Mascolo A, Magli R, Saladino I
Eur J Gynaecol Oncol. 1982;3(2):101-6.
The authors studied the HSV-TAA (Herpes Simplex Virus Tumor Associated Antigen) in patients affected by female genitale tract tumors, using the immunoenzymatic assay (ELISA). They found a positive frequence of 65% in sera of patients affected by uterine cervical carcinoma and of the 80% in sera of patients affected by vulvar carcinoma. The authors suggest that this enzymatic method has a real value and propose its use in the early diagnosis of the female genital tract neoplasms.
作者使用免疫酶测定法（ELISA）对患有女性生殖道肿瘤的患者进行了单纯疱疹病毒肿瘤相关抗原（HSV-TAA）的研究。他们发现，子宫颈癌患者血清中的阳性率为65%，外阴癌患者血清中的阳性率为80%。作者认为这种酶法具有实际价值，并建议将其用于女性生殖道肿瘤的早期诊断。
